The role of apatinib combined with paclitaxel (aluminum binding type) in platinum-resistant ovarian cancer

OBJECTIVE: To assess the anti-tumor activity and side effects of different dosages of paclitaxel (albumin binding type) (hereinafter referred to as nab-P) combined with Apatinib (hereinafter referred to as AP) in platinum-resistant ovarian cancer cell line and xenograft models. METHODS: SKOV-3/DDP c...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Ovarian Res
Asıl Yazarlar: Zhao, Hong, Li, Rong, Wang, Xiaoyan, Lu, Xin, Hu, Min, Zhang, Jinbin, Zhao, Xia, Song, Xiaoqin, Liu, Yangyang
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2020
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7507263/
https://ncbi.nlm.nih.gov/pubmed/32958014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-020-00719-3
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller